High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis

Opis bibliograficzny
Główni autorzy:	Blackman, D, Porto, I, Channon, K, Banning, A
Format:	Conference item
Wydane:	2003

Podobne zapisy

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
od: Blackman, D, i wsp.
Wydane: (2004)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
od: Porto, I, i wsp.
Wydane: (2005)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
od: Nisha Ohri, MD, i wsp.
Wydane: (2016-01-01)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
od: Violeta Dinesch, i wsp.
Wydane: (2017-04-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
od: Negar Faramarzi, i wsp.
Wydane: (2015-10-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
od: Sohila Refahi, i wsp.
Wydane: (2019-03-01)

Risk assessment score for drug eluting stent restenosis
od: Z. A. Gabbasov, i wsp.
Wydane: (2018-09-01)

Paclitaxel eluting stents versus bare metal stents restenosis
od: Ronald Aroche Aportela, i wsp.
Wydane: (2021-12-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
od: Mohamed Aboel-Kassem F. Abdelmegid, i wsp.
Wydane: (2017-04-01)

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.
od: De Caterina, A, i wsp.
Wydane: (2013)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
od: Kakhaber Etsadashvili, i wsp.
Wydane: (2011-06-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
od: Yen-Wen Liu, i wsp.
Wydane: (2021-09-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
od: Omar A. Meelu, MS, i wsp.
Wydane: (2017-03-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
od: Ganesh Paramasivam, i wsp.
Wydane: (2019-11-01)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
od: Luo Y, i wsp.
Wydane: (2022-02-01)

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
od: Abizaid, A, i wsp.
Wydane: (2012)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
od: Jorge A Arroyave C, i wsp.
Wydane: (2012-06-01)

Safety of MRI early after implantation of a drug-eluting stent.
od: Porto, I, i wsp.
Wydane: (2004)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
od: Birong Liu, i wsp.
Wydane: (2024-12-01)

The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions
od: Kazunori Horie, MD, i wsp.
Wydane: (2025-01-01)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
od: Chengbin Zheng, i wsp.
Wydane: (2019-01-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
od: Mohammad Saifur Rohman, i wsp.
Wydane: (2023-07-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
od: Ganesh Paramasivam, i wsp.
Wydane: (2019-12-01)

The Role Of Inflammation In Stent Restenosis More Than 1 Year Afetr Drug Eluting Stent Implantation
od: Hasan Shemirani, i wsp.
Wydane: (2011-09-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
od: Yi-Xing Yang, i wsp.
Wydane: (2020-01-01)

Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty
od: Mohd Shah, Azarisman Shah, i wsp.
Wydane: (2011)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
od: Aslı Tanındı, i wsp.
Wydane: (2015-07-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
od: Murat Gençbay
Wydane: (2015-07-01)

Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
od: Yu-Ling Hsu, i wsp.
Wydane: (2023-07-01)

In Stent Restenosis After Drug-Eluting Stent Implantation in a Patient with Polycythemia Vera: A Case Report
od: I Gusti Ayu Ratna Dewi, i wsp.
Wydane: (2023-06-01)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
od: Xiaohang Yuan, i wsp.
Wydane: (2023-08-01)

Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate
od: Dauer Cheryl, i wsp.
Wydane: (2005-12-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
od: Guillaume Marquis-Gravel, i wsp.
Wydane: (2017-09-01)

Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft.
od: Ponnuthurai, F, i wsp.
Wydane: (2007)

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
od: Ahmed Abdelaziz, i wsp.
Wydane: (2024-11-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
od: Wen-Juan Xiu, i wsp.
Wydane: (2018-01-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
od: Chih-Yuan Fang, i wsp.
Wydane: (2018-04-01)

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
od: Alain Guidon, i wsp.
Wydane: (2008-01-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
od: Wenjie Yang, i wsp.
Wydane: (2025-01-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
od: Hongfei Xi, i wsp.
Wydane: (2023-03-01)